ArticlePharmacoepidemiology and drug safety2025
Impact of Lookback Duration on the Performance of a Claims-Based Frailty Proxy in Women With Stage I-III Breast Cancer.
Emilie D Duchesneau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.